APA (7th ed.) Citation

Sommerer, C. (2016). Design and rationale of the ATHENA study: A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. Trials, 17, . https://doi.org/10.1186/s13063-016-1220-9

Chicago Style (17th ed.) Citation

Sommerer, Claudia. "Design and Rationale of the ATHENA Study: A 12-month, Multicentre, Prospective Study Evaluating the Outcomes of a De Novo Everolimus-based Regimen in Combination with Reduced Cyclosporine or Tacrolimus Versus a Standard Regimen in Kidney Transplant Patients: Study Protocol for a Randomised Controlled Trial." Trials 17 (2016). https://doi.org/10.1186/s13063-016-1220-9.

MLA (9th ed.) Citation

Sommerer, Claudia. "Design and Rationale of the ATHENA Study: A 12-month, Multicentre, Prospective Study Evaluating the Outcomes of a De Novo Everolimus-based Regimen in Combination with Reduced Cyclosporine or Tacrolimus Versus a Standard Regimen in Kidney Transplant Patients: Study Protocol for a Randomised Controlled Trial." Trials, vol. 17, 2016, https://doi.org/10.1186/s13063-016-1220-9.